You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. We no longer send these by email as we did in […]| New Cannabis Ventures
High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter¹ CALGARY, AB, Aug. 14, 2025 /PRNewswire/ […]| New Cannabis Ventures
Cannabis stocks, as measured by the Global Cannabis Stock Index, passed the anniversary a year go when they exploded higher in late August on news that the Department of Health and Human Services had recommended to the DEA that it move cannabis from Schedule 1 to... #ayrwellness #AYRWF #gnln| New Cannabis Ventures